X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
index medicus (24) 24
female (23) 23
adult (22) 22
aged (22) 22
male (22) 22
middle aged (22) 22
hematology (17) 17
prognosis (14) 14
oncology (13) 13
cancer (12) 12
leukemia, myeloid, acute - drug therapy (11) 11
mutation (11) 11
acute myeloid leukemia (10) 10
chemotherapy (10) 10
leukemia (10) 10
treatment outcome (10) 10
survival (9) 9
therapy (9) 9
abridged index medicus (8) 8
aged, 80 and over (8) 8
leukemia, myeloid, acute - genetics (7) 7
leukemia, myeloid, acute - mortality (7) 7
life sciences (7) 7
survival rate (7) 7
acute myeloid-leukemia (6) 6
adolescent (6) 6
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
drug administration schedule (6) 6
hemic and lymphatic diseases (6) 6
acute myelogenous leukemia (5) 5
disease-free survival (5) 5
hematology, oncology and palliative medicine (5) 5
immunology (5) 5
leukemia, myeloid, acute - diagnosis (5) 5
patients (5) 5
recurrence (5) 5
risk (5) 5
survival analysis (5) 5
young adult (5) 5
adults (4) 4
aml (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - adverse effects (4) 4
article (4) 4
azacitidine (4) 4
care and treatment (4) 4
cell biology (4) 4
clinical trials (4) 4
diagnosis (4) 4
dosage and administration (4) 4
follow-up studies (4) 4
france (4) 4
gemtuzumab ozogamicin (4) 4
gene expression (4) 4
health aspects (4) 4
leukemia, myeloid, acute - pathology (4) 4
leukemia, myeloid, acute - therapy (4) 4
minimal residual disease (4) 4
mylotarg (4) 4
remission induction (4) 4
retrospective studies (4) 4
usage (4) 4
[sdv.can]life sciences [q-bio]/cancer (3) 3
acute promyelocytic leukemia (3) 3
age factors (3) 3
aminoglycosides - therapeutic use (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
azacitidine - therapeutic use (3) 3
cells (3) 3
child (3) 3
child, preschool (3) 3
chronic myeloid-leukemia (3) 3
cytarabine (3) 3
cytogenetics (3) 3
dose-response relationship, drug (3) 3
elderly-patients (3) 3
expression (3) 3
incidence (3) 3
medicine (3) 3
medicine, general & internal (3) 3
mortality (3) 3
mutations (3) 3
myelodysplastic syndrome (3) 3
philadelphia chromosome (3) 3
prospective studies (3) 3
recommendations (3) 3
risk assessment (3) 3
risk factors (3) 3
safety (3) 3
salvage therapy (3) 3
stem cell transplantation (3) 3
transplantation (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
[sdv]life sciences [q-bio] (2) 2
acute lymphatic leukemia (2) 2
acute lymphoblastic-leukemia (2) 2
acute lymphocytic-leukemia (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1508 - 1516
Journal Article
Journal Article
Journal Article
Nature, ISSN 0028-0836, 12/2016, Volume 540, Issue 7633, pp. 433 - 437
Journal Article
Journal Article
by Bulsei, Julie and Leroy, Sylvie and Perotin, Jeanne-Marie and Mal, Hervé and Marquette, Charles-Hugo and Dutau, Hervé and Bourdin, Arnaud and Vergnon, Jean-Michel and Pison, Christophe and Kessler, Romain and Jounieaux, Vincent and Salaün, Mathieu and Marceau, Armelle and Dukic, Sylvain and Barbe, Coralie and Bonnaire, Margaux and Deslee, Gaëtan and Durand-Zaleski, Isabelle and Dury, Sandra and Vallerand, Hervé and Lebargy, François and Launois, Claire and Pradelli, Johanna and Benzaquen, Jonathan and Buscot, Matthieu and Sanfiorenzo, Celine and Korzeniewski, Sylvia and Mazzetta, Andrea and Griffonnet, Jennifer and Guillemart, Ariane and Makris, Demosthenes and Dombret, Marie Christine and Servin, Frédérique and Debray, Marie Pierre and Laroumagne, Sophie and Bregeon, Fabienne and Gomez, Carine and Astoul, Philippe and Lesavre, Nathalie and Mallet, Jean Pierre and Gamez, Anne Sophie and Tarodo, Philippe and Brousse, Christophe and Broissin, Clément and Thibout, Yoann and Di Palma, Fabrice and Costes, Frédéric and Briault, Amandine and Arbib, François and Reymond, Emilie and Ferrettti, G and Porzio, Michele and Renaud-Picard, Benjamin and Toublanc, Bénédicte and François, Géraldine and Thiberville, Luc and Cuvelier, Antoine and Lachkar, Samy and Gras, Delphine and Benoit, Philippe and Leclainche, Annick and Jolly, Damien and Fourrier, François and Hachulla, Eric and Roche, Nicolas and Dusser, Daniel and REVOLENS Study Grp and REVOLENS study group and the REVOLENS study group
Respiratory Research, ISSN 1465-9921, 05/2018, Volume 19, Issue 1, pp. 84 - 9
Background: The REVOLENS study compared lung volume reduction coil treatment to usual care in patients with severe emphysema at 1 year, resulting in improved... 
QALY | Coil treatment | Cost-effectiveness | Severe emphysema | TRIAL | RESPIRATORY SYSTEM | Bronchoscopy | Care and treatment | Usage | Emphysema, Pulmonary | Analysis | Research | Medical care, Cost of | Life Sciences
Journal Article